Latest Study Provides Evidence Confirming the Mechanism of Action of Vasomedical’s EECP Therapy in Treating Cardiovascular Disease
VasoHealthcare Holds Launch Summit 2010 In Greensboro, NC
Vasomedical Releases iPhone Application for EECP® Therapy
Vasomedical Announces Reorganization of Its Board of Directors
Vaso Healthcare, a Subsidiary of Vasomedical, Inc. Signs Exclusive Sales Representative Agreement with GE Healthcare
More >>
Offered exclusively by Vasomedical, Inc. EECP therapy is a safe, non-invasive, outpatient treatment option for patients suffering from ischemic heart diseases such as angina and heart failure. EECP therapy has helped thousands of patients. In fact, clinical studies show, over 75% of patients benefit from EECP therapy and sustain improvement up to three years post- treatment.
Vasomedical-BIOX Model1305, 3-Channel ECG Holter Recorder
CB Series Analysis